Menu
Log in


Log in

Duke Ob/Gyn's 2023 Magazine

February 14, 2023 1:01 PM | Sarah Brady (Administrator)

From Duke Ob/Gyn Chair Matthew D. Barber, MD, MHS: I am proud to share with you our newest edition of Duke Ob/Gyn’s annual magazine, showcasing the outstanding work that we are accomplishing on a local, national and global scale. The impact of our work will touch many lives and provide hope for countless women locally and beyond.

Click here to access the digital version (scroll down to access links to individual magazine articles). In the coming week, over 24,000 printed copies will be mailed to physicians, health care leaders, alumni and friends, and supporters of Duke Ob/Gyn to highlight just some of the great work we are doing.

As you read this issue of our annual publication, you will note the exceptional work and excellence that has been achieved as we translate research from bench to bedside — and provide hope to our patients and their families. Here are just some of the highlights:

  • In commemoration of the 50th anniversary of Duke Cancer Institute and the 50th anniversary of the Division of Gynecologic Oncology, you’ll see a compilation of truly extraordinary work in this field, and a look at what the future holds.
  • New findings demonstrate a practice-changing paradigm shift for urogynecologists consistent with trials in other fields, which have shown that early activity doesn’t impede outcomes and may improve them in some circumstances.
  • A multidisciplinary team in Duke’s Müllerian Anomalies Program brings the necessary skillset to offer each patient the best possible solution, coordinating surgical care, recovery and long-term follow-up not possible at most hospital centers across the country.
  • Popular TikTok videos related to intrauterine devices (IUDs) tend to depict negative patient experiences related to pain, while some videos conveyed unreliable information. Duke Ob/Gyn led a study to analyze patients’ personal experiences.
  • Work in global health continues to impact cervical cancer diagnostic screening through clinical translation of a diagnostic algorithm: Colposcopy Aided Risk Evaluation (CARE). And an innovative, real-world experiment to potentially measure the possible effects of exposure to per- and polyfluoroalkyl compounds (PFAS) on maternal health is underway in partnership with the Duke Global Health Institute.

Thank you for taking the time to learn about how Duke Ob/Gyn is a leader in cutting-edge research, specialized care delivery and life-changing results.


Contact Us
Office: 919.668.3948
Fax: 919.668.5547

Duke University School of Medicine

201 Trent Drive

203 Baker House

DUMC Box 3084

Durham, NC 27710

Powered by Wild Apricot Membership Software